Raab & Moskowitz Asset Management LLC Ionis Pharmaceuticals Inc Transaction History

Raab & Moskowitz Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $133,993 - $204,211	-3,221 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $173,450 - $210,234	3,221 New	3,221 $194,000
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $190,940 - $233,260	-3,233 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$52.92 - $81.17 $171,090 - $262,422	3,233 New	3,233 $262,000
Q4 2018 Feb 04, 2019	SELL	$43.37 - $59.54 $140,215 - $192,492	-3,233 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $138,631 - $173,612	3,233 New	3,233 $166,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.